Search Results

MilliporeSigma and The Michael J. Fox Foundation for Parkinson’s Research (MJFF), are advancing research aimed at slowing progression of Parkinson’s disease (PD).

June 18, 2024

·

4 min read

Press Releases

MilliporeSigma Partners with Opentrons Labworks, Inc., Supporting Lab of the Future

January 23, 2025

·

5 min read

Genetown

MilliporeSigma Announces Siren Biotechnology as Winner of its North American Advance Biotech Grant

MilliporeSigma, the U.S. and Canada Life Science business of Merck KGaA, Darmstadt, Germany, announced that Siren Biotechnology has been selected as the North American winner of its 13th Advance Biotech Grant Program.

June 4, 2024

·

5 min read

Genetown

MilliporeSigma Launches First Software for Complete Data Traceability in Microbial Quality Control

MilliporeSigma, the U.S. and Canada Life Science business of Merck KGaA, Darmstadt, Germany, a leading science and technology company, has launched its M-Trace® Software & Mobile App, a comprehensive data tracking solution to digitize sterility testing.

May 28, 2024

·

5 min read

Deals

MilliporeSigma Signs Definitive Agreement to Acquire Mirus Bio, Furthering Ambition to Be a Leading Supplier for Viral Vector Manufacturing

MilliporeSigma, the U.S. and Canada Life Science business of Merck KGaA, Darmstadt, Germany, today announced the signing of a definitive agreement to acquire Mirus Bio for US$ 600 million.

May 22, 2024

·

4 min read

Genetown

MilliporeSigma Launches First All-in-One Genetic Stability Assay to Accelerate Biosafety Testing

MilliporeSigma, the U.S. and Canada Life Science business of Merck KGaA, Darmstadt, Germany, launched the first all-in-one, validated genetic stability assay of its kind.

April 16, 2024

·

4 min read